1 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-10,67 % |
+19,87 % |
-0,65 |
2 |
CH0113817123 |
Bellevue Biotech DT CHF |
-13,69 % |
+20,18 % |
-0,79 |
3 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
-10,90 % |
+19,70 % |
-0,67 |
4 |
LU1897414568 |
Janus Henderson Horizon Biotechnology Fund IU2 USD |
-15,88 % |
+27,24 % |
-0,67 |
5 |
LU1897414485 |
Janus Henderson Horizon Biotechnology Fund H2 USD |
-16,02 % |
+27,22 % |
-0,67 |
|
11 |
LU0108459040 |
Candriam Equities L Biotechnology C - Thesaurierung |
-12,94 % |
+20,03 % |
-0,76 |
|
73 |
LU0774687577 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP |
-23,25 % |
+20,32 % |
-1,26 |
74 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-16,87 % |
+13,70 % |
-1,40 |
75 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-17,45 % |
+13,70 % |
-1,44 |
76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-41,24 % |
+30,82 % |
-1,41 |
77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-41,32 % |
+30,81 % |
-1,42 |